Personalized Intravenous (IV) Insulin Therapy to Achieve the Safest Patient Outcomes

You can choose any or all of the four corners of the image on the right to have cutouts. To avoid medication errors and ensure patients are receiving the safest insulin dose requires a systematic approach that eliminates risks and personalizes insulin doses for each patient.

Hospital IV
50/50 with double headings

Improves Compliance and Reduces the Risk of Insulin Dosing

EndoTool IV offers a straightforward software solution to recommend a personalized insulin dose when intravenous insulin is administered to manage hyperglycemia.

Hospitals using EndoTool IV have demonstrated better
patient outcomes , including:

95 %

A 95% reduction in hypoglycemia

1
54 %

A 54% decrease in hospital acquired infection

1
3 hrs

Less than 3 hours average time to control

2
46 %

A 46% reduction in finger sticks

1
100 %

100% protocol adherance

3

Two Thirds Centered

Using a non-linear dosing model and machine-learning approach, EndoTool IV
translates past data points into an individual physiological model for each patient

With Background Color & Image

It is estimated that one-third of all patients will experience hyperglycemia during their time within the hospital.1 This includes patients who have a diagnosis of diabetes, but also those without preexisting diabetes who experience stress-induced hyperglycemia. Achieving glucose targets among all patients is a critical aspect of delivering quality care. Uncontrolled blood glucose can lead to greater complications, longer length of stay, and increased costs.2

Two Thirds / One Third - Image Right

You can choose whether to have the image on the left or right in these blocks.

Rather than using a fixed multiplier or linear protocol, EndoTool uses proprietary technology to model, predict and adapt each patient’s dosing recommendation. The dosing recommendation is based on 11 patient- specific factors, including the presence of steroids, kidney function and residual insulin.

Two Thirds / One Third - Image Left

Similar in concept to the subcutaneous “insulin on board,” Estimated Residual Extracellular Insulin (EREI) refers to residual insulin present in a patient’s body from previous doses. EndoTool IV contains an algorithm that triggers the software to down regulate an insulin dose to adjust for residual insulin circulating in the blood stream to help prevent hypoglycemia.

Two Thirds One Third with Notched Image

Research has demonstrated that that patients who experience higher glucose levels are at an increased risk of infection. Following general surgery, one study found rates of postoperative infection climbed 30% with every 40-point elevation from normoglycemia, defined as less than 110 mg/dL.3

Content with Title and Background

  • Endotool IV is flexible and customizable with recommended parameters that can be modified down to the unit level, to support the organization’s standard of practice and internal policies.
  • The system is capable of full integration with your Electronic Medical Record
  • Your team is supported 24/7/365 by EndoTool IT and Clinical Experts
  • Designated users can track performance and dive deeper with advanced analytics
Large Cards

Want to learn more about the EndoTool IV?

Let's Talk!
EndoTool IV Data Sheet

Check out EndoTool IV’s Unique Capabilities and Key Benefits

Download Our EndoTool Sell Sheet
Single large card

Want to learn more about the EndoTool IV?

Let's Talk!
Make your Case for EndoTool

Support your pitch for improved glycemic management with information on how EndoTool benefits clinical, IT, and finance stakeholders

A True Precision Medicine Tool for Inpatient Glucose Management

Proven, complex algorithms to model, predict and adapt dosing recommendations to each patient and their individual response for more precise, safer inpatient insulin therapy.

F586F657-346D-4743-A3D6-F3A6633C81AD Created with sketchtool.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat ipsum dolor sit amet, consectetuer adipiscing elit.

50CF5941-3E63-4B1F-8560-BF2966A901A6 Created with sketchtool.

Lorem ipsum dolor sit amet, consectetuer adipiscing elit, sed diam nonummy nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat ipsum dolor sit amet, consectetuer adipiscing elit.